Table 1 Clinical characteristics of patients with DR and BRVO

Participants/Eyes (n)

146

142

–

Gender (male %)

52.0

48.0

–

Age (yrs)

55.34 ± 14.77

56.94 ± 19.28

0.497

BCVA (logMAR) (mean ± SD)

0.53 ± 0.21

0.55 ± 0.13

0.333

CME duration (m)

7.61 ± 8.13

5.77 ± 3.14

0.172

CFT (μm)

532.24 ± 76.33

545.55 ± 80.97

0.152

CME without SRF

69 (47.2%)

78 (54.9%)

0.240

CME with SRF

77 (52.7%)

64 (45.0%)

HEs area (mean ± SD)

0.61 ± 0.35

0.55 ± 0.58

0.287

 Absent

38 (26.0%)

41 (28.9%)

0.704

 Minimal (> 0–0.1 mm²)

44 (30.1%)

47 (33.1%)

0.719

 Mild (> 0.1–0.5 mm²)

33 (22.6%)

29 (20.4%)

0.780

 Moderate (> 0.5–2.5 mm²)

23 (15.8%)

18 (12.7%)

0.616

 Severe (> 2.5 mm²)

8 (5.5%)

7 (4.9%)

0.842

 Total cholesterol (mmol/L)

4.41 ± 0.96

4.69 ± 0.88

0.231

 Triglyceride (mmol/L)

1.33 ± 0.48

1.36 ± 0.32

0.575

 LDL-C (mmol/L)

2.26 ± 0.21

2.19 ± 0.53

0.226

 HDL-C (mmol/L)

1.09 ± 0.17

1.15 ± 0.43

0.201